CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy. (nature.com)

Authors: Ho M … Fraietta JA Journal: Nature Medicine Published: 2026-02-01 DOI: https://doi.org/10.1038/s41591-025-04121-8